BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 838398)

  • 1. Detection, by three techniques, of hepatitis B surface antigen (HBsAg) and determination of HBsAg and anti-HBs titres in patients with chronic liver disease.
    Chiaramonte M; Heathcote J; Crees M; Sherlock S
    Gut; 1977 Jan; 18(1):1-6. PubMed ID: 838398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of antibody to hepatitis B core antigen by radioimmunoassay in chronic liver disease.
    Mizuno M; Yamada G; Sakamoto Y; Yumoto Y; Nagashima H
    Acta Med Okayama; 1980 Jun; 34(3):155-60. PubMed ID: 6251699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological evidence of hepatitis B infection in patients with chronic liver diseases: radioimmunoassay of HBsAg and anti-HBs.
    Skinhöj P; Nielsen JO; Dietrichson O
    Scand J Gastroenterol; 1977; 12(5):615-9. PubMed ID: 918556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of antibody formation to HBsAg in the pathogenesis of chronic hepatitis and cirrhosis?
    Schlicht I; Gadow J; Ortmans H; Jorno L; Gentz HD; Wolter G; Hoppe I
    Acta Hepatogastroenterol (Stuttg); 1979 Dec; 26(6):450-6. PubMed ID: 549426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-occurrence of HBsAg and anti-HBs: two consecutive infections or a sign of advanced chronic liver disease?
    Heijtink RA; van Hattum J; Schalm SW; Masurel N
    J Med Virol; 1982; 10(2):83-90. PubMed ID: 6183398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
    Dávid K; Halmy L
    Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus infection and chronic liver disease in Taiwan.
    Chen DS; Sung JL
    Acta Hepatogastroenterol (Stuttg); 1978 Dec; 25(6):423-30. PubMed ID: 214987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of assay methods for hepatitis B surface (HBsAg) antigen and its antibody (anti-HBs) in viral hepatitis B (VHB)-HBsAg-positive.
    Mudrić V; Vuković B; Dimić E; Borota R
    Med Microbiol Immunol; 1978 Nov; 166(1-4):195-200. PubMed ID: 102913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sensitive single reverse passive haemagglutination test for detecting both HBsAg and anti-HBs.
    Barbara JA; Harrison PJ; Howell DR; Cleghorn TE; Dane DS; Briggs M; Cameron CH
    J Clin Pathol; 1979 Nov; 32(11):1180-3. PubMed ID: 512031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of human antibodies to hepatitis B surface antigen (HBsAg) by an enzyme-immunoassay for HBsAg.
    Wolters G; Kuijpers L; Schuurs A
    J Clin Pathol; 1979 Dec; 32(12):1264-71. PubMed ID: 395171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus (HBV) markers among patients with chronic liver disease in Kuwait.
    Al-Nakib B; Al-Nakib W; Bayoumi A; Al-Liddawi H; Bashir AA
    Trans R Soc Trop Med Hyg; 1982; 76(3):348-50. PubMed ID: 7112657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B antigens and antibodies in asymptomatic carriers and in chronic liver diseases.
    Nakamura S; Takezawa Y; Sato T; Maeda T; Nakamura M; Kera K
    Tohoku J Exp Med; 1979 May; 128(1):81-7. PubMed ID: 452007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease.
    Eleftheriou N; Thomas HC; Heathcote J; Sherlock S
    Lancet; 1975 Dec; 2(7946):1171-3. PubMed ID: 53657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radioimmunological determination of HBeAg/anti-HBe in HBsAg-positive liver diseases and in "healthy" HBsAg carriers].
    Arnold W; Hess G; Dormeyer HH; Gahl G; Hoffmann HG; Knolle J; Schönborn H
    Z Gastroenterol; 1979 Oct; 17(10):704-12. PubMed ID: 118595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of serum hepatitis B surface antigen (HBsAg) and serum anticore with tissue HBsAg and hepatitis B core antigen (HBcAg).
    Omata M; Afroudakis A; Liew CT; Ashcavai M; Peters RL
    Gastroenterology; 1978 Dec; 75(6):1003-9. PubMed ID: 710851
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibodies to hepatitis B surface and core antigens in haemophiliacs and their contacts among hospital personnel.
    Hansson BG
    Scand J Infect Dis; 1977; 9(3):167-9. PubMed ID: 905782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HBe Ag/anti-HBe system: results of a study of 66 patients having the hepatitis B surface antigen (HBsAG)].
    Lemaire JM; Borgeot C; Mourrut C; Michel H
    Nouv Presse Med; 1978 Sep; 7(32):2878. PubMed ID: 714681
    [No Abstract]   [Full Text] [Related]  

  • 19. [The incidence of serum anti-HBc and anti-HBs and tissue HBcAg in patients with HBsAg-negative hepatopathy].
    Giuliani-Piccari G; Orlandi G; Roccuzzo S; D'Imperio N; Formica G; Piemontese A; Sarti F
    G Clin Med; 1981 Feb; 62(2):94-102. PubMed ID: 7239059
    [No Abstract]   [Full Text] [Related]  

  • 20. Presence of HBsAg and anti-HBs in patients with primary liver cancer or hepatic metastases.
    Nastac E; Stoian M; Iosipenco M; Iordache C
    Virologie; 1985; 36(3):181-6. PubMed ID: 3000067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.